- Home
- RZLT vs JSPR Comparison
RZLT vs JSPR Comparison
Compare RZLT & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- JSPR
- Stock Information
- Founded
- RZLT 2010
- JSPR 2018
- Country
- RZLT United States
- JSPR United States
- Employees
- RZLT N/A
- JSPR N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RZLT Health Care
- JSPR Health Care
- Exchange
- RZLT Nasdaq
- JSPR Nasdaq
- Market Cap
- RZLT 626.4M
- JSPR 47.6M
- IPO Year
- RZLT N/A
- JSPR N/A
- Fundamental
- Price
- RZLT $7.47
- JSPR $2.38
- Analyst Decision
- RZLT Strong Buy
- JSPR Buy
- Analyst Count
- RZLT 5
- JSPR 12
- Target Price
- RZLT $12.50
- JSPR $30.78
- AVG Volume (30 Days)
- RZLT 854.2K
- JSPR 150.8K
- Earning Date
- RZLT 11-06-2025
- JSPR 11-06-2025
- Dividend Yield
- RZLT N/A
- JSPR N/A
- EPS Growth
- RZLT N/A
- JSPR N/A
- EPS
- RZLT N/A
- JSPR N/A
- Revenue
- RZLT N/A
- JSPR N/A
- Revenue This Year
- RZLT N/A
- JSPR N/A
- Revenue Next Year
- RZLT N/A
- JSPR N/A
- P/E Ratio
- RZLT N/A
- JSPR N/A
- Revenue Growth
- RZLT N/A
- JSPR N/A
- 52 Week Low
- RZLT $2.22
- JSPR $2.27
- 52 Week High
- RZLT $8.34
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- RZLT 59.74
- JSPR 27.23
- Support Level
- RZLT $6.92
- JSPR $2.50
- Resistance Level
- RZLT $8.34
- JSPR $2.87
- Average True Range (ATR)
- RZLT 0.34
- JSPR 0.13
- MACD
- RZLT -0.03
- JSPR -0.01
- Stochastic Oscillator
- RZLT 38.87
- JSPR 8.96
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.